The quality of research on judicialization and its influence on public policies on access to medicines in Brazil: a systematic review

• Autor(a) principal: Lyra,Pollyanna Farias Castro Pereira de
• Data de Publicação: 2021
• Outros Autores: Araújo,Dyego Carlos Souza Anacleto de, Santos Júnior,Genival Araújo dos, Sodré-Alves,Bárbara Manuella Cardoso, Jesus,Elisdete Maria Santos de, Lyra Jr.,Divaldo Pereira de, Quintans Jr.,Lucindo José
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Ciência & Saúde Coletiva (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232021001105577
• topic: Right to health; Medicines; Judicial decisions; Access to medicines; Drug costs

Abstract Patients without access to medicines often resort to the judicial system. However, no systematic review has discussed the quality of studies and the factors that may influence the access to medicines from judicialization. This study aimed to characterize the quality of research on access to judicialized medicines and their influence on public policies in Brazil. A search was conducted in the LILACS, PubMed/Medline, Scopus, and Web of Science databases using the terms “judicialization” and “medication”. Two reviewers identified articles that met the inclusion criteria. Only studies written in English, Portuguese, or Spanish published from 1990 to 2018 were included. The study selection resulted in a final sample of 45 articles. The retrospective descriptive design was the most common methods, based on reports and lawsuits. A high level of heterogeneity among the studies hindered the comparison and generation of evidence capable of supporting judges’ decisions based on technical-scientific criteria. This review showed that studies were heterogeneous and had low methodological quality. Moreover, they did not propose viable solutions for health managers and formulators to face the problem.